Single-molecule imaging study reveals altered morphology and elevated mobility in fulvestrant-bound estrogen receptor alpha, suggesting distinct conformational shifts driving degradation.
Fulvestrant is a selective estrogen receptor downregulator (SERD) that antagonizes estrogen receptor α (ERα) and also promotes receptor degradation. However, how it affects full-length ERα dynamics at the single-molecule level remains unclear. Here, we used high-speed atomic force microscopy (HS-AFM) to directly visualize the dynamic behavior of full-length ERα under fulvestrant-bound, ligand-free, and other ligand-bound conditions. Among the four conditions, fulvestrant-bound ERα alone showed a reduced apparent molecular volume and increased surface mobility, behaving distinctly from the ligand-free, E2-bound, and 4-OHT-bound states. These results indicate that fulvestrant not only drives ERα inactivation and degradation but also is associated with changes in the observed molecular morphology and dynamics of full-length ERα. Our study provides direct single-molecule observation of altered molecular behavior under fulvestrant-bound conditions, which we interpret as reflecting changes in the conformational ensemble of full-length ERα.
No takes yet. Share an insight, caveat, or question.
Imakawa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: